1066 — Shandong Weigao Medical Polymer Co Balance Sheet
0.000.00%
- HK$16.82bn
- HK$13.79bn
- CNY13.39bn
Annual balance sheet for Shandong Weigao Medical Polymer Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
R2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | HKAS | HKAS | HKAS | HKAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 7,133 | 6,964 | 6,989 | 8,322 | 9,453 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 6,142 | 7,654 | 7,717 | 7,506 | 8,281 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 16,260 | 18,288 | 18,634 | 19,443 | 20,663 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 6,726 | 7,320 | 7,335 | 7,342 | 7,529 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 30,578 | 33,402 | 33,670 | 34,760 | 36,048 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 5,178 | 6,005 | 7,582 | 6,081 | 5,472 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 11,171 | 11,635 | 11,221 | 11,008 | 11,940 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 19,407 | 21,767 | 22,449 | 23,752 | 24,108 |
| Total Liabilities & Shareholders' Equity | 30,578 | 33,402 | 33,670 | 34,760 | 36,048 |
| Total Common Shares Outstanding |